Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

HIPK2 neutralizes MDM2 inhibition rescuing p53 transcriptional activity and apoptotic function

Oncogene volume 23, pages 5185–5192 (2004)Cite this article

Abstract

The p53 oncosuppressor protein is subject to negative regulation by MDM2, which efficiently inhibits its activity through an autoregulatory loop. In response to stress, however, p53 undergoes post-translational modifications that allow the protein to escape MDM2 control, accumulate, and become active. Recent studies have shown that, following DNA damage, the HIPK2 serine/threonine kinase binds and phosphorylates p53, inducing p53 transcriptional activity and apoptotic function. Here, we investigated the role of HIPK2 in the activation of p53 in the presence of MDM2. We found that HIPK2 rescues p53 transcriptional activity overcoming MDM2 inhibition, and that restoration of this p53 function induces apoptosis. Recovery of p53-dependent apoptosis is achieved by preventing p53 nuclear export and ubiquitination mediated by MDM2 in vitro and in vivo following genotoxic stress. These results shed new light on the mechanisms by which the HIPK2/p53 pathway promotes apoptosis and suppression of tumorigenesis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Appella E and Anderson CW . (2001). Eur. J. Biochem., 268, 2764–2772.

  • Barak Y, Juven T, Haffner R and Oren M . (1993). EMBO J., 12, 461–468.

  • Bulavin DV, Saito S, Hollander MC, Sakaguchi K, Anderson CW, Appella E and Fornace AJ . (1999). EMBO J., 18, 6845–6854.

  • Chen J, Wu X, Lin J and Levine AJ . (1996). Mol. Cell. Biol., 16, 2445–2452.

  • Chene P . (2003). Nat. Rev. Cancer, 3, 102–109.

  • Craig AL, Burch L, Vojtesek B, Mikutowska J, Thompson A and Hupp TR . (1999). Biochem. J., 342, 133–141.

  • D'Orazi G, Cecchinelli B, Bruno T, Manni I, Higashimoto Y, Saito S, Gostissa M, Coen S, Marchetti A, Del Sal G, Piaggio G, Fanciulli M and Soddu S . (2002). Nat. Cell Biol., 4, 11–19.

  • Di Stefano V, Rinaldo C, Sacchi A, Soddu S and D'Orazi G . (2004). Exp. Cell Res., 293, 311–320.

  • Eymin B, Gazzeri S, Brambilla C and Brambilla E . (2002). Oncogene, 21, 2750–2761.

  • Freedman DA and Levine AJ . (1998). Mol. Cell. Biol., 18, 7288–7293.

  • Fuchs SY, Fried VA and Ronai Z . (1998). Oncogene, 17, 1483–1490.

  • Giaccia J and Kastan LB . (1998). Genes Dev., 12, 2973–2983.

  • Gottlieb TM and Oren M . (1996). Biochim. Biophys. Acta, 1287, 77–102.

  • Haupt Y, Barak Y and Oren M . (1996). EMBO J., 15, 1596–1606.

  • Haupt Y, Maya R, Kazaz A and Oren M . (1997). Nature, 387, 296–299.

  • Hofmann TG, Moller A, Sirma H, Zentgraf H, Taya Y, Droge W, Will H and Schmitz ML . (2002). Nat. Cell Biol., 4, 1–10.

  • Jones SN, Roe AE, Donehower LA and Bradley A . (1995). Nature, 378, 206–208.

  • Kim E-J, Park J-S and Um S-J . (2002). J. Biol. Chem., 277, 32020–32028.

  • Kubbutat MH, Jones SN and Vousden KH . (1997). Nature, 387, 299–303.

  • Lakin ND and Jackson S . (1999). Oncogene, 1, 7644–7655.

  • Leite KR, Franco MF, Srougi M, Nesrallah LJ, Nesrallah A, Bevilacqua RG, Darini E, Carnalho M, Meirelles MI, Santana I and Camara-Lopes LH . (2001). Mod. Pathol., 12, 428–436.

  • Lu H and Levine AJ . (1995). Proc. Natl. Acad. Sci. USA, 92, 5154–5158.

  • Miyashita T and Reed JC . (1995). Cell, 80, 293–299.

  • Moll UM, Riou G and Levine AJ . (1992). Proc. Natl. Acad. Sci. USA, 89, 7262–7266.

  • Momand J, Jung D, Wilczynski S and Niland J . (1998). Nucleic Acid Res., 26, 3453–3459.

  • Momand J, Zambett GP, Olson DC, Gorge D and Levine AJ . (1992). Cell, 69, 1237–1245.

  • Montes de Oca Luca R, Wagner DS and Lozano G . (1995). Nature, 378, 203–206.

  • Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yanashita T, Tokino T, Taniguchi T and Tanaka N . (2000a). Science, 288, 1053–1058.

  • Oda K, Arakawa H, Tanaka T, Matsuda K, Tanikawa C, Mori T, Nishimori H, Tamai K, Tokino T, Nakamura Y and Taya Y . (2000b). Cell, 102, 849–862.

  • Oliner JD, Kinzler KW, Meltzer PS, George DL and Vogelstein B . (1992). Nature, 358, 80–83.

  • Picksley SM and Lane DP . (1993). BioEssay, 15, 689–690.

  • Polsky D, Bastian BC, Hazan C, Melzer K, Pack J, Houghton A, Busan K, Cordon-Cardo C and Osman I . (2001). Cancer Res., 61, 7642–7646.

  • Polyak K, Xia Y, Zweir JL, Kinzler KW and Vogelstein B . (1997). Nature, 389, 300–305.

  • Prives C . (1998). Cell, 95, 5–8.

  • Prives C and Hall PA . (1999). J. Pathol., 187, 112–126.

  • Roth J, Dobbelstein M, Freedman DA, Shenk T and Levine AJ . (1998). EMBO J., 17, 554–564.

  • Sakaguchi K, Saito S, Higashimoto Y, Roy S, Anderson CW and Appella E . (2000). J. Biol. Chem., 275, 9278–9283.

  • Shieh S-Y, Ikeda M, Taya Y and Prives C . (1997). Cell, 9, 325–334.

  • Siliciano JD, Canman CE, Taya Y, Sakaguchi K, Appella E and Kastan MB . (1997). Genes Dev., 11, 3471–3481.

  • Tao W and Levine AJ . (1999). Proc. Natl. Acad. Sci. USA, 96, 3077–3080.

  • Unger T, Juven-Gershon T, Moallem E, Berger M, Vogt Sionov R, Lozano G, Oren M and Haupt Y . (1999). EMBO J., 18, 1805–1814.

  • Unger T, Nau MM, Segal S and Minna JD . (1992). EMBO J., 11, 1383–1390.

  • Valculescu VE and El Deiry WS . (1996). Clin. Chem., 42, 858–868.

  • Vogt Sionov R and Haupt Y . (1999). Oncogene, 18, 6145–6157.

  • Vousden KH . (2000). Cell, 103, 691–694.

  • Wang Y, Bedatin K-M and Hug H . (2001). BMC Mol. Biol., 2, 8–16.

  • Wu X, Bayle JH, Olson D and Levine AJ . (1993). Genes Dev., 7, 1126–1132.

Download references

Acknowledgements

This work was supported by grants from Associazione Italiana Ricerca sul Cancro (AIRC), Ministero Sanità, FIRB, MIUR-CNR, and MIUR Fondi Ateneo. We gratefully acknowledge constructive criticisms and helpful discussion by Dr F Moretti, Dr S Bacchetti, and Dr A Porrello.

Author information

Authors and Affiliations

  1. Department of Experimental Oncology, Molecular Oncogenesis Laboratory, Regina Elena Cancer Institute, Rome, 00158, Italy

    Valeria Di Stefano, Giovanni Blandino, Ada Sacchi, Silvia Soddu & Gabriella D'Orazi

  2. Department of Oncology and Neurosciences, University ‘G D'Annunzio’, Chieti, 66013, Italy

    Gabriella D'Orazi

Authors
  1. Valeria Di Stefano
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Giovanni Blandino
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ada Sacchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Silvia Soddu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gabriella D'Orazi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gabriella D'Orazi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stefano, V., Blandino, G., Sacchi, A. et al. HIPK2 neutralizes MDM2 inhibition rescuing p53 transcriptional activity and apoptotic function. Oncogene 23, 5185–5192 (2004). https://doi.org/10.1038/sj.onc.1207656

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207656

Keywords

This article is cited by

Search

Advanced search

Quick links